6609 — Shanghai HeartCare Medical Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
HK$650.86m
Enterprise Value
-HK$90.72m
Revenue
CNY232.34m

Annual income statement for Shanghai HeartCare Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	14.6	90.1	183	232
Cost of Revenue
Gross Profit	0	7.09	55	124	164
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	75.4	229	286	347	333
Operating Profit	-75.4	-215	-196	-164	-101
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-75.5	-216	-198	-201	-103
Provision for Income Taxes
Net Income After Taxes	-75.5	-216	-198	-200	-94
Minority Interest
Net Income Before Extraordinary Items
Net Income	-75.5	-214	-194	-200	-94
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-75.5	-214	-194	-200	-94
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.94	-5.2	-4.86	-5.24	-2.47